Ad is loading...
FSEP vs KOCT
FSEP vs KOCT Comparison Chart
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
FSEP vs. KOCT commentary
Feb 24, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSEP is a Hold and KOCT is a StrongBuy.
SUMMARIES
FUNDAMENTALS
Fundamentals
FSEP has more net assets: 861M vs. KOCT (85.8M). FSEP has a higher annual dividend yield than KOCT: FSEP (1.789) vs KOCT (-0.158). FSEP was incepted earlier than KOCT: FSEP (4 years) vs KOCT (5 years).
| FSEP | KOCT | FSEP / KOCT | |
| Gain YTD | 1.789 | -0.158 | -1,130% |
| Net Assets | 861M | 85.8M | 1,003% |
| Total Expense Ratio | N/A | N/A | - |
| Turnover | 0.00 | N/A | - |
| Yield | 0.00 | 0.00 | - |
| Fund Existence | 4 years | 5 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| FSEP | KOCT | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 55% | N/A |
| Stochastic ODDS (%) | 3 days ago 52% | 3 days ago 54% |
| Momentum ODDS (%) | 3 days ago 64% | 3 days ago 65% |
| MACD ODDS (%) | 3 days ago 47% | 3 days ago 58% |
| TrendWeek ODDS (%) | 3 days ago 61% | 3 days ago 64% |
| TrendMonth ODDS (%) | 3 days ago 65% | 3 days ago 71% |
| Advances ODDS (%) | 5 days ago 66% | 19 days ago 69% |
| Declines ODDS (%) | 3 days ago 59% | 3 days ago 64% |
| BollingerBands ODDS (%) | 3 days ago 56% | 3 days ago 78% |
| Aroon ODDS (%) | 3 days ago 61% | 3 days ago 58% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PGSLX | 10.50 | -0.01 | -0.10% |
| Principal Global Sus Lstd Inf Inst | |||
| PHLAX | 35.05 | -0.19 | -0.54% |
| PGIM Jennison Health Sciences A | |||
| AAISX | 16.85 | -0.11 | -0.65% |
| American Beacon International Eq Adv | |||
| TIIRX | 26.96 | -0.56 | -2.03% |
| Nuveen Core Equity A | |||
| DNFGX | 40.87 | -0.89 | -2.13% |
| Dunham Focused Large Cap Growth N | |||